Updates from the Fourth International Congress 'psoriasis: from gene to clinic', the Royal College of Physicians, London, UK, 1-3 December 2005.
The fourth 'Psoriasis: From Gene to Clinic' meeting was held in December 2005, its international status confirmed by the presence of almost 300 delegates from Europe, North America, Asia and Australasia. The meeting was co-organized by Jonathan Barker (St John's Institute of Dermatology, London) and Chris Griffiths (University of Manchester), who once again deserve congratulations for the success of their initiative. As its title suggests, the meeting was targeted at both clinical and basic scientists with a special interest in psoriasis, but in preparing this report the writer has selected presentations that caught his attention and that he felt able to review in a manner that might be of interest to the general readership of this Journal.
Camp
R D R
RD
Department of Infection, Immunity and Inflammation, University of Leicester, Maurice Shock Medical Sciences Building, University Road, Leicester, UK. rdrc1@le.ac.uk
D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000627:therapeutic use; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy; D008131:London; D011565:Psoriasis / Q000235:genetics / Q000276:immunology / Q000628:therapy; D013290:Streptococcal Infections / Q000150:complications; D013297:Streptococcus pyogenes; D013601:T-Lymphocytes / Q000276:immunology
D023181:Antimicrobial Cationic Peptides